Central Anticholinergic Syndrome on Therapeutic Doses of Cyproheptadine

Watemberg et al discuss the case of a child who developed central anticholinergic syndrome (CAS) while on therapeutic doses of cyproheptadine for migraine prophylaxis.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 1999-01, Vol.103 (1), p.158-160
Hauptverfasser:	Watemberg, Nathan M, Roth, Karl S, Alehan, Fusun K, Epstein, Cynthia E
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Case studies Central Nervous System Diseases - chemically induced Child Cholinergic Antagonists - administration & dosage Cholinergic Antagonists - adverse effects Cyproheptadine - administration & dosage Cyproheptadine - adverse effects Drug therapy Drug toxicity and drugs side effects treatment Hallucinations - chemically induced Humans Male Medical disorders Medical sciences Migraine Disorders - prevention & control Pediatrics Pharmacology. Drug treatments Serotonin Antagonists - adverse effects Toxicity Toxicity: nervous system and muscle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Watemberg et al discuss the case of a child who developed central anticholinergic syndrome (CAS) while on therapeutic doses of cyproheptadine for migraine prophylaxis.
ISSN:	0031-4005 1098-4275
DOI:	10.1542/peds.103.1.158